All News Privia Health Group, Inc.

Equities

PRVA

US74276R1023

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-15 pm EDT			5-day change	1st Jan Change
17.37 ^USD	-3.77%		-7.90%	-24.58%

May. 15	Truist Securities Adjusts Price Target on Privia Health Group to $24 From $28, Keeps Buy Rating	MT
May. 10	UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Truist Securities Adjusts Price Target on Privia Health Group to $24 From $28, Keeps Buy Rating	May. 15	MT
UBS Adjusts Privia Health Group Price Target to $26.50 From $29, Maintains Buy Rating	May. 10	MT
Transcript : Privia Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Privia Health Group Adjusted Earnings, Revenue Rise in Q1; Offers Full Year 2024 Revenue Guidance	May. 09	MT
Privia Health: Q1 Earnings Snapshot	May. 09	AQ
Earnings Flash (PRVA) PRIVIA HEALTH GROUP Posts Q1 Revenue $415.2M, vs. Street Est of $394.8M	May. 09	MT
Earnings Flash (PRVA) PRIVIA HEALTH GROUP Reports Q1 EPS $0.18, vs. Street Est of $0.15	May. 09	MT
Privia Health Reports First Quarter 2024 Financial Results	May. 09	AQ
Privia Health Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Privia Health Group, Inc. Reiterates Earnings Guidance for the Year 2024	May. 09	CI
NuvoAir Medical Partners with Privia Medical Group, Georgia to Help Transform Cardiopulmonary Care with Virtual-First Care Model	May. 01	AQ
Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target	Apr. 22	MT
Privia Health to Report First Quarter 2024 Results on Thursday, May 9	Apr. 09	AQ
Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating	Mar. 19	MT
JPMorgan Cuts Price Target on Privia Health to $30 From $38, Maintains Overweight Rating	Mar. 06	MT
Barclays Starts Coverage on Privia Health With Equalweight Rating, $22 Price Target	Mar. 06	MT
UBS Adjusts Privia Health Group Price Target to $29 From $31, Maintains Buy Rating	Mar. 01	MT
TD Cowen Adjusts Price Target on Privia Health to $26 From $30, Maintains Outperform Rating	Mar. 01	MT
Truist Securities Cuts Price Target on Privia Health Group to $28 From $32, Maintains Buy Rating	Feb. 29	MT
Privia Health Group's Q4 Adjusted Earnings, Revenue Rise; 2024 Revenue Outlook Issued -- Shares Rise Pre-Bell	Feb. 27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Privia Health Group, Inc.

Equities

PRVA

US74276R1023

All News

Filters